<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Human Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28434495</article-id>
      <article-id pub-id-type="pmc">5420346</article-id>
      <article-id pub-id-type="publisher-id">S0002-9297(17)30114-3</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2017.03.009</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Srour</surname>
            <given-names>Myriam</given-names>
          </name>
          <email>myriam.srour@mcgill.ca</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">10</xref>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shimokawa</surname>
            <given-names>Noriaki</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="fn1" ref-type="fn">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hamdan</surname>
            <given-names>Fadi F.</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nassif</surname>
            <given-names>Christina</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Poulin</surname>
            <given-names>Chantal</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al Gazali</surname>
            <given-names>Lihadh</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosenfeld</surname>
            <given-names>Jill A.</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Koibuchi</surname>
            <given-names>Noriyuki</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rouleau</surname>
            <given-names>Guy A.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al Shamsi</surname>
            <given-names>Aisha</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Michaud</surname>
            <given-names>Jacques L.</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
          <xref rid="aff9" ref-type="aff">9</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Pediatrics, McGill University, Montreal, QC H3A 1A4, Canada</aff>
      <aff id="aff2"><label>2</label>Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 1A4, Canada</aff>
      <aff id="aff3"><label>3</label>Department of Integrative Physiology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan</aff>
      <aff id="aff4"><label>4</label>Department of Nutrition, Takasaki University of Health and Welfare, Gunma 370-0033, Japan</aff>
      <aff id="aff5"><label>5</label>Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada</aff>
      <aff id="aff6"><label>6</label>Department of Paediatrics, College of Medicine &amp; Health Sciences, United Arab Emirates University, PO box 15551, Al Ain, United Arab Emirates</aff>
      <aff id="aff7"><label>7</label>Baylor College of Medicine, Houston, TX 77030, USA</aff>
      <aff id="aff8"><label>8</label>Department of Paediatrics, Tawam Hospital, PO box 15258, Al-Ain, United Arab Emirates</aff>
      <aff id="aff9"><label>9</label>Departments of Pediatrics and Neurosciences, Universit&#xE9; de Montr&#xE9;al, Montreal, QC H3T 1J4, Canada</aff>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author <email>myriam.srour@mcgill.ca</email></corresp>
        <fn id="fn1">
          <label>10</label>
          <p id="ntpara0010">These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>04</day>
        <month>5</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>4</month>
        <year>2017</year>
      </pub-date>
      <volume>100</volume>
      <issue>5</issue>
      <fpage>824</fpage>
      <lpage>830</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>11</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2017 American Society of Human Genetics.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>American Society of Human Genetics</copyright-holder>
      </permissions>
      <abstract id="abs0010">
        <p>Glucose transport across the blood brain barrier and into neural cells is critical for normal cerebral physiologic function. Dysfunction of the cerebral glucose transporter GLUT1 (encoded by <italic>SLC2A1</italic>) is known to result in epilepsy, intellectual disability (ID), and movement disorder. Using whole-exome sequencing, we identified rare homozygous missense variants (c.526C&gt;T [p.Arg176Trp] and c.629C&gt;T [p.Ala210Val]) in <italic>SLC45A1</italic>, encoding another cerebral glucose transporter, in two consanguineous multiplex families with moderate to severe ID, epilepsy, and variable neuropsychiatric features. The variants segregate with the phenotype in these families, affect well-conserved amino acids, and are predicted to be damaging by in&#xA0;silico programs. Intracellular glucose transport activity of the p.Arg176Trp and p.Ala210Val SLC45A1 variants, measured in transfected COS-7 cells, was approximately 50% (p = 0.013) and 33% (p = 0.008) lower, respectively, than that of intact SLC45A1. These results indicate that residues at positions 176 and 210 are critical for the glucose transport activity of SLC45A1. All together, our data strongly suggest that recessive mutations in <italic>SLC45A1</italic> cause ID&#xA0;and epilepsy. SLC45A1 thus represents the second cerebral glucose transporter, in addition to GLUT1, to be involved in neurodevelopmental disability. Identification of additional individuals with mutations in <italic>SLC45A1</italic> will allow better definition of the associated phenotypic spectrum and the exploration of potential targeted treatment options.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>epilepsy</kwd>
        <kwd>
          <italic>SLC45A1</italic>
        </kwd>
        <kwd>
          <italic>PAST-A</italic>
        </kwd>
        <kwd>
          <italic>DNB5</italic>
        </kwd>
        <kwd>cerebral glucose transporter</kwd>
        <kwd>intellectual disability</kwd>
        <kwd>autism</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: April 20, 2017</p>
    </notes>
  </front>
</article>
</pmc-articleset>